Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors

Affiliations

• ¹ Laboratory of Immunopharmacology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil (R.M.-G., M.C., L.P., I.G.A.-Q., J.R.T., E.D.H., P.T.B.).
• ² Postgraduate Program in Immunology and Inflammation, Federal University of Rio de Janeiro (UFRJ), Brazil (R.M.-G., M.C.).
• ³ D'Or Institute for Research and Education, Rio de Janeiro, Brazil (M.A.M., P.H.R.d.C., F.A.B., R.S.R.).
• ⁴ Center for Technological Development in Health (CDTS), FIOCRUZ, RJ, Brazil (J.R.T.).
• ⁵ Laboratory on Thymus Research, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ, Brazil (J.R.T.).
• ⁶ National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, RJ, Brazil (J.R.T.).
• ⁷ Department of Radiology, Federal University of Rio de Janeiro, Brazil (J.d.T.M., P.H.R.d.C., R.S.R.).
• ⁸ National Institute of Infectious Disease Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil (F.A.B.).
• ⁹ Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil (E.D.H.).